Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (4023)	6/6/2001 9:56:06 AM
From: rkrw	Read Replies (1) \| Respond to of 52153

Michael, I don't think it's that thestreet puts out negative stories on biotech, it's that they often lack balance. I personally don't care if they run a negative story on a company, but when dealing with drug developers (or anyone), at least provide both sides and then I would have no complaints. When providing such little balance they run the risk of appearing to be pawns of short sellers, not credible reporters. People also assume Cramer has a role in every article published by thestreet although I can only assume that he has little at all do with their day to day work. I'm with you, let's all put this aside!